Roof BS, Gordon GS, Goldman L, et al: Berson and Yalow's radio immunoassay for parathyroid hormone PTH: A clinical progress report . Mt Sinai J Med NY 40:433-447, 1973;.
Balsan S, Garabedian M, Sogniard R, et al: 1,25-dihydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3 in children: Biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance . Pediatr Res 9:586-593, 1975;.
Brickman AS, Coburn JW, Massry SG, et al: 1,25-dihydroxyvitamin D, in normal man and in patients with renal failure . Ann Intern Med 80:161-168, 1974;.
Chan JCM, Oldham SB, Holick MF, et al: 1-α-hydroxyvitamin D3 in chronic renal failure: A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol . JAMA 234:47-52, 1975;.
Chan JCM, Oldham SB, DeLuca HF: Effectiveness of 1-alpha-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysis . J Pediatr 90:820-824, 1977;.
Wang M, Rao DD, Mauger I, et al: Nutritional aspects of children on hemodialysis or following renal transplantation , in Chan JCM (ed): Symposium on Kidney Failure: Dialysis and Transplantation in Childhood. Clin Proc Child Hosp Natl Med Center 30:259-264, 1974;.
Chan JCM: The effect of milk formulae on acid-balance . Nutr Metab 16:140-154, 1974;.
Mitch WE, Walser M, Buffinton GA, et al: A simple method of estimating progression of chronic renal failure . Lancet 2:1326-1328, 1976;.
Rutherford WE, Blondin J, Miller JP, et al: Chronic progressive renal disease: Rate of change of serum creatinine concentration . Kidney Int 11:62-70, 1977;.
Chan JCM, Beale MG: The progression of end-stage kidney disease in children: Effect of dietary therapy , in Chan JCM (ed): Symposium on Kidney Failure: Dialysis and Transplantation in Childhood. Clin Proc Child Hosp Natl Med Center 30:202-206, 1974;.
Hausler MR, Baylink EJ, Hughes MR, et al: The assay of 1-alpha 25 dihydroxyvitamin D3: Physiologic and pathologic modulation of circulating hormone levels . Clin Endocrinol 5(
(suppl)
): 151, 1976;.
Avioli LV, Teitelbaum SL: The renal osteodystrophies , in Brenner M, Rector FC (eds): The Kidney . Philadelphia, WB Saunders Co, 1976;, pp 1542-1591.
Berson SA, Yalow RS: Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia and bronchogenetic carcinoma . Sci NY 153:907-909, 1966;.
Arnaud CD: Hyperparathyroidism and renal failure . Kidney Int 4:89-94, 1973;.
Reiss E, Canterbury JM, Kanter A: Circulating parathyroid hormone concentration in chronic renal insufficiency . Arch Intern Med 124:417-421, 1969;.
Holick MF, deBlanco MD, Clark MB, et al: The metabolism of (6-3H) 1 alpha-hydroxycholecalciferol to (6-3H) 1 alpha-25-dihydroxycholecalciferol in a patient with renal insufficiency . J Clin Endocrinol Metab 44:595-598, 1977;.
Evans IM, Boulton-Jones M, Doyle FH, et al: The clinical use of synthetic 1,25-dihydroxycholecalciferol . Calcif Tissue Res 21(
(suppl)
):236-241, 1976;.
Ellis HA, Pert KM: Iliac bone marrow mast cells in relation to the renal osteodystrophy of patients treated with hemodialysis . J Clin Pathol 29:502-516, 1976;.
Chesney RW, Moorthy AV, Eisman JA, et al: Increased growth after long-term oral 1,25-vitamin D3 in childhood renal osteodystrophy . N Engl J Med 298:238-242, 1978;.
Piel CF, Roof BS, Avioli LV: Metabolism of tritiated 25-hydroxycholecalciferol in chronically uremic children before and after successful renal homotransplantation . J Clin Endocrinol Metab 37:944-948, 1973;.